Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1-mutant cholangiocarcinoma.
Zabransky DJ, Kartalia E, Lee JW, Leatherman JM, Charmsaz S, Young SE, Chhabra Y, Franch-Expósito S, Kang M, Maru S, Rastkari N, Davis M, Dalton WB, Oshima K, Baretti M, Azad NS, Jaffee EM, Yarchoan M.
Zabransky DJ, et al. Among authors: oshima k.
Hepatology. 2024 Dec 3. doi: 10.1097/HEP.0000000000001185. Online ahead of print.
Hepatology. 2024.
PMID: 39626209